Health Care & Life Sciences » Pharmaceuticals | Pa Shun Pharmaceutical International Holdings Ltd.

Pa Shun Pharmaceutical International Holdings Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,002
1,066
1,071
1,006
1,003
973
Cost of Goods Sold (COGS) incl. D&A
817
849
867
873
900
901
Gross Income
185
217
203
132
103
71
SG&A Expense
71
89
127
109
65
82
EBIT
112
127
76
20
39
11
Unusual Expense
20
48
45
13
17
33
Non Operating Income/Expense
18
20
21
27
16
3
Interest Expense
7
11
5
3
18
19
Pretax Income
103
90
139
33
22
58
Income Tax
23
32
35
24
11
18
Consolidated Net Income
80
58
105
9
12
75
Net Income
80
58
109
9
12
70
Net Income After Extraordinaries
80
58
109
9
12
70
Net Income Available to Common
80
58
109
9
12
70
EPS (Basic)
0.08
0.00
0.14
0.01
0.01
0.06
Basic Shares Outstanding
1,000
1,000
780
1,000
1,007
1,117
EPS (Diluted)
0.10
0.06
0.07
0.01
0.01
0.06
Diluted Shares Outstanding
1,000
1,000
884
1,001
1,007
1,117
EBITDA
117
140
88
29
46
5
Other Operating Expense
2
1
-
3
1
-
Non-Operating Interest Income
-
2
2
3
2
1
Minority Interest Expense
-
-
4
-
-
5

About Pa Shun Pharmaceutical International Holdings

View Profile
Address
Unit 1803, 18/F
Hong Kong
Hong Kong
Employees -
Website -
Updated 07/08/2019
Pa Shun International Holdings Ltd. engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Pharmaceutical Distribution, Self-Operated Retail Pharmacies, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution segment sells pharmaceutical products to wholesalers, franchise retail pharmacy chain stores, and hospitals and other medical institutions in rural areas.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.